May need wider eczema caution for kids: FDA | Reuters

Links shared publicly online about this topic.

  • 1,305
    total visits

May need wider eczema caution for kids: FDA | Reuters

reuters.com

WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug Administration

View full resource at reuters.com

Tags: Infection, Cancer, Drug, Pharma, Children's Health, FDA, Novartis, Astellas Pharma

  • Share

Most Recently Shared on March 19, 2010 at 12:00 am By:

hrana Hisham Rana, MD

News: Novartis & Astellas eczema drugs may need wider warnings due to reports of cancer and infection in kids. http://bit.ly/da9b0c #pharma

2 years ago...

May need wider eczema caution for kids: FDA | Reuters

feeds.reuters.com — “WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug AdministrationView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 18, 2010 at 2:37 pm By:

HITpol HealthIT Policy Health IT and Health News

May need wider eczema caution for kids: FDA: WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs m... http://bit.ly/ddTrEi

2 years ago...

May need wider eczema caution for kids: FDA | Reuters

feeds.reuters.com — “WASHINGTON (Reuters) - Novartis AG and Astellas Pharma eczema drugs may need their warning labels expanded after dozens of new reported cases of cancer and infection in children, U.S. Food and Drug AdministrationView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on March 18, 2010 at 2:18 pm By:

Advertisement